Literature DB >> 1581207

New tools for clinical evaluation of erythron function in man.

M Cazzola1, Y Beguin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1581207     DOI： 10.1111/j.1365-2141.1992.tb08133.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

1.  Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.

Authors:  Eugenia Mendoza; Ximena Duque; Segundo Moran; Gloria Martínez-Andrade; Elba Reyes-Maldonado; Samuel Flores-Huerta; Homero Martinez
Journal:  Ann Hematol       Date:  2021-01-30       Impact factor: 3.673

Review 2.  Markers of iron status in chronic kidney disease.

Authors:  Adam E Gaweda
Journal:  Hemodial Int       Date:  2017-03-22       Impact factor: 1.812

Review 3.  The potential adverse effects of haemolysis.

Authors:  Francesca Rapido
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

4.  Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

Authors:  Wattana Leowattana; Srivicha Krudsood; Noppadon Tangpukdee; Gary Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2008-07       Impact factor: 0.267

5.  Serum transferrin receptors in rheumatoid arthritis.

Authors:  A Zoli; L Altomonte; L Mirone; M Magaró; B M Ricerca; S Storti; A Candido; M Bizzi
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

6.  The role of intravenous iron in the treatment of anemia in cancer patients.

Authors:  H Tilman Steinmetz
Journal:  Ther Adv Hematol       Date:  2012-06

Review 7.  Inadequate erythropoietin response to anemia: definition and clinical relevance.

Authors:  G Barosi
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

Review 8.  Iron dosing in kidney disease: inconsistency of evidence and clinical practice.

Authors:  Adam E Gaweda; Yelena Z Ginzburg; Yossi Chait; Michael J Germain; George R Aronoff; Eliezer Rachmilewitz
Journal:  Nephrol Dial Transplant       Date:  2014-05-12       Impact factor: 5.992

9.  Impact of epoetin beta on quality of life in patients with malignant disease.

Authors:  M Boogaerts; B Coiffier; C Kainz
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

10.  Hepatic manifestations in hematological disorders.

Authors:  Jun Murakami; Yukihiro Shimizu
Journal:  Int J Hepatol       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.